Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hong-Yu Li

Showing results (261-270 of 282) with videos related to

Pageof 29
Sort By:
Biomedicines|September 28, 2021
Albumin Fusion at the N-Terminus or C-Terminus of HM-3 Leads to Improved Pharmacokinetics and BioactivitiesTing Li, Han-Zi Zhang, Guang-Fei Ge, et al.
Nature Communications|December 9, 2025
NMDA receptors coordinate brain vascular development via neuron-to-endothelial tip cell crosstalk in zebrafishTing-Ting Liu, Hong-Yu Li, Shan-Ye Gu, et al.
Gut Pathogens|December 9, 2020
Genomic patterns and characterizations of chromosomally-encoded mcr-1 in Escherichia coli populationsCong Shen, Lan-Lan Zhong, Furong Ma, et al.
Journal of Medicinal Chemistry|January 27, 2022
Discovery of N-Trisubstituted Pyrimidine Derivatives as Type I RET and RET Gatekeeper Mutant Inhibitors with a Novel Kinase Binding PoseLingtian Zhang, Marialuisa Moccia, David C Briggs, et al.
Science China. Life Sciences|March 26, 2025
RIG-I-driven CDKN1A stabilization reinforces cellular senescenceCui Wang, Xiaoyu Jiang, Hong-Yu Li, et al.
Oncotarget|January 14, 2016
EM23, a natural sesquiterpene lactone, targets thioredoxin reductase to activate JNK and cell death pathways in human cervical cancer cellsFang-Yuan Shao, Sheng Wang, Hong-Yu Li, et al.
Nature Communications|March 9, 2024
Mi-2β promotes immune evasion in melanoma by activating EZH2 methylationCang Li, Zhengyu Wang, Licheng Yao, et al.
Science (New York, N.Y.)|March 19, 2026
Hypothalamic clock governs circadian painHong-Rui Wei, Qianqian Lou, Le-Xian Li, et al.
World Journal of Gastroenterology|December 16, 2024
Bidirectional associations among gallstone disease, non-alcoholic fatty liver disease, kidney stone diseaseGuo-Heng Jiang, Sheng Li, Hong-Yu Li, et al.
Journal of Medicinal Chemistry|March 17, 2006
Dihydropyrrolopyrazole transforming growth factor-beta type I receptor kinase domain inhibitors: a novel benzimidazole series with selectivity versus transforming growth factor-beta type II receptor kinase and mixed lineage kinase-7Hong-yu Li, Yan Wang, Charles R Heap, et al.
Pageof 29

Showing results (261-270 of 282) with videos related to

Sort By:
Pageof 29
Biomedicines|September 28, 2021
Albumin Fusion at the N-Terminus or C-Terminus of HM-3 Leads to Improved Pharmacokinetics and BioactivitiesTing Li, Han-Zi Zhang, Guang-Fei Ge, et al.
Nature Communications|December 9, 2025
NMDA receptors coordinate brain vascular development via neuron-to-endothelial tip cell crosstalk in zebrafishTing-Ting Liu, Hong-Yu Li, Shan-Ye Gu, et al.
Gut Pathogens|December 9, 2020
Genomic patterns and characterizations of chromosomally-encoded mcr-1 in Escherichia coli populationsCong Shen, Lan-Lan Zhong, Furong Ma, et al.
Journal of Medicinal Chemistry|January 27, 2022
Discovery of N-Trisubstituted Pyrimidine Derivatives as Type I RET and RET Gatekeeper Mutant Inhibitors with a Novel Kinase Binding PoseLingtian Zhang, Marialuisa Moccia, David C Briggs, et al.
Science China. Life Sciences|March 26, 2025
RIG-I-driven CDKN1A stabilization reinforces cellular senescenceCui Wang, Xiaoyu Jiang, Hong-Yu Li, et al.
Oncotarget|January 14, 2016
EM23, a natural sesquiterpene lactone, targets thioredoxin reductase to activate JNK and cell death pathways in human cervical cancer cellsFang-Yuan Shao, Sheng Wang, Hong-Yu Li, et al.
Nature Communications|March 9, 2024
Mi-2β promotes immune evasion in melanoma by activating EZH2 methylationCang Li, Zhengyu Wang, Licheng Yao, et al.
Science (New York, N.Y.)|March 19, 2026
Hypothalamic clock governs circadian painHong-Rui Wei, Qianqian Lou, Le-Xian Li, et al.
World Journal of Gastroenterology|December 16, 2024
Bidirectional associations among gallstone disease, non-alcoholic fatty liver disease, kidney stone diseaseGuo-Heng Jiang, Sheng Li, Hong-Yu Li, et al.
Journal of Medicinal Chemistry|March 17, 2006
Dihydropyrrolopyrazole transforming growth factor-beta type I receptor kinase domain inhibitors: a novel benzimidazole series with selectivity versus transforming growth factor-beta type II receptor kinase and mixed lineage kinase-7Hong-yu Li, Yan Wang, Charles R Heap, et al.
Pageof 29